1-1331506-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152228.3(TAS1R3):c.161G>A(p.Arg54Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000193 in 1,602,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152228.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS1R3 | NM_152228.3 | c.161G>A | p.Arg54Gln | missense_variant | 1/6 | ENST00000339381.6 | NP_689414.2 | |
TAS1R3 | XM_017002435.2 | c.161G>A | p.Arg54Gln | missense_variant | 1/5 | XP_016857924.1 | ||
TAS1R3 | XM_017002436.2 | c.161G>A | p.Arg54Gln | missense_variant | 1/5 | XP_016857925.1 | ||
TAS1R3 | XM_047431571.1 | c.161G>A | p.Arg54Gln | missense_variant | 1/6 | XP_047287527.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS1R3 | ENST00000339381.6 | c.161G>A | p.Arg54Gln | missense_variant | 1/6 | 2 | NM_152228.3 | ENSP00000344411 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000318 AC: 7AN: 220120Hom.: 0 AF XY: 0.0000165 AC XY: 2AN XY: 121382
GnomAD4 exome AF: 0.0000207 AC: 30AN: 1450138Hom.: 0 Cov.: 31 AF XY: 0.0000180 AC XY: 13AN XY: 720758
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152230Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74370
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2022 | The c.161G>A (p.R54Q) alteration is located in exon 1 (coding exon 1) of the TAS1R3 gene. This alteration results from a G to A substitution at nucleotide position 161, causing the arginine (R) at amino acid position 54 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at